A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
Razeghian E, Nasution MKM, Rahman HS, Gardanova ZR, Abdelbasset WK, Aravindhan S, Bokov DO, Suksatan W, Nakhaei P, Shariatzadeh S, Marofi F, Yazdanifar M, Shamlou S, Motavalli R, Khiavi FM.
Razeghian E, et al. Among authors: bokov do.
Stem Cell Res Ther. 2021 Jul 28;12(1):428. doi: 10.1186/s13287-021-02510-7.
Stem Cell Res Ther. 2021.
PMID: 34321099
Free PMC article.
Review.